Clinical Trial Update: PACEVALUE: Development of a Risk Score to Predict Pacing-Induced Cardiomyopathy in Patients Undergoing Pacemaker or ICD Implantation and Evaluation of Patient Outcomes and Cost-Effectiveness Across Different Healthcare Systems

View source ↗

Summary

The PACEVALUE study is investigating a risk score to predict pacing-induced cardiomyopathy in patients with pacemakers or ICDs and evaluating patient outcomes a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Arrhythmias
• Cardiomyopathy
• Heart Failure
• Pacing-induced Cardiomyopathy

Snippet

Sponsor: Insel Gruppe AG, University Hospital Bern | Conditions: Cardiomyopathy, Secondary, Arrhythmias, Cardiac | Status: ACTIVE_NOT_RECRUITING